Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × belinostat × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, T-Cell, Peripheral 3 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 Uveal Melanoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Mycosis Fungoides 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Eye Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1 Blast Crisis 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05154994 2026-01-27

RESOLVE

University of Utah

Phase 1 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡